← Open Payments lookup

RICHARD CAIN: Open Payments

NPI 1700236510 · LIVINGSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,211 in 63 payments from 15 companies in 2025. Trend: 2023 $1,410 · 2024 $1,468 · 2025 $1,211

Food & beverage: $1,211
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP11$225
Bayer Healthcare Pharmaceuticals Inc.10$192
Novo Nordisk Inc9$164
GlaxoSmithKline, LLC.7$144
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$82
Viatris Specialty LLC4$79
Amgen Inc.3$57
ABBVIE INC.3$55
Sumitomo Pharma America, Inc.2$49
Inspire Medical Systems, Inc.2$48

Products named: Kerendia, TRELEGY ELLIPTA, AIRSUPRA, BREZTRI, Rybelsus, XIFAXAN, YUPELRI, Ozempic.

Industry payments across TX — which companies pay providers there.